Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
2020 · Biomedicine & Pharmacotherapy · 55 citations
https://doi.org/10.1016/j.biopha.2020.110316
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
2.1K
Citations
21
h-index
34
i10-index
Yu Gu is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 21, co-authored 88 publications.
ORCID: 0000-0002-5683-8078https://doi.org/10.1016/j.biopha.2020.110316
https://doi.org/10.1186/1479-5876-11-164
https://doi.org/10.1245/s10434-023-14366-7
https://doi.org/10.6084/m9.figshare.21952766
Click to start Chat